IDEX (NYSE:IEX) Announces Earnings Results

by · The Cerbat Gem

IDEX (NYSE:IEX – Get Free Report) posted its quarterly earnings data on Wednesday. The industrial products company reported $2.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.04 by $0.06, FiscalAI reports. IDEX had a return on equity of 15.20% and a net margin of 13.97%.The company had revenue of $899.10 million for the quarter, compared to the consensus estimate of $882.00 million. During the same period in the previous year, the business earned $2.04 EPS. IDEX’s revenue for the quarter was up 4.2% compared to the same quarter last year. IDEX updated its Q1 2026 guidance to 1.730-1.780 EPS and its FY 2026 guidance to 8.150-8.35 EPS.

Here are the key takeaways from IDEX’s conference call:

  • IDEX’s Health & Science Technologies (HST) segment showed strong momentum with 34% organic orders growth in Q4, ~$493M in segment orders and broad demand in data-center, semiconductor, space/defense and related applications, giving management higher conviction for HST into 2026.
  • The company reported better-than-expected Q4 results with adjusted EBITDA margin +40 bps, an adjusted EPS beat, and strong cash generation — $617M free cash flow for FY‑2025 (103% conversion), ~$1.1B liquidity and ~$250M of share repurchases in 2025.
  • 2026 guidance is modestly paced: organic growth 1%–2%, adjusted EBITDA margin targeted at 26.5%–27% and adjusted EPS of $8.15–$8.35, reflecting mid-single-digit HST growth offset by flat-to-down FMT and FSDP.
  • Industrial-facing segments remain soft — FMT saw only +4% orders/+1% sales and FSDP had flat orders and -5% sales, with ongoing weakness in chemicals, energy, agriculture and international fire & safety demand and no clear macro inflection yet.
  • Capital allocation remains shareholder-friendly and disciplined: focus on tuck‑in M&A (integrating Micro‑LAM), maintaining investment‑grade leverage, a dividend target of 30%–35% of adjusted net income, and a base repurchase cadence (~$75M/quarter assumption).

IDEX Price Performance

NYSE IEX traded up $6.84 on Wednesday, hitting $208.45. 469,171 shares of the company were exchanged, compared to its average volume of 735,408. The company has a current ratio of 2.93, a quick ratio of 2.06 and a debt-to-equity ratio of 0.47. The company has a market cap of $15.60 billion, a P/E ratio of 33.01, a P/E/G ratio of 1.99 and a beta of 1.00. The firm has a 50 day moving average of $184.24 and a two-hundred day moving average of $172.50. IDEX has a 1-year low of $153.36 and a 1-year high of $209.55.

IDEX Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 30th. Stockholders of record on Friday, January 16th were paid a $0.71 dividend. This represents a $2.84 annualized dividend and a dividend yield of 1.4%. The ex-dividend date was Friday, January 16th. IDEX’s dividend payout ratio is currently 44.94%.

Institutional Trading of IDEX

Several hedge funds have recently added to or reduced their stakes in IEX. CYBER HORNET ETFs LLC acquired a new position in IDEX in the second quarter valued at about $35,000. MUFG Securities EMEA plc bought a new position in IDEX in the second quarter valued at approximately $39,000. Employees Retirement System of Texas bought a new stake in shares of IDEX during the third quarter worth $99,000. Advisory Services Network LLC acquired a new stake in shares of IDEX during the third quarter worth $105,000. Finally, Parallel Advisors LLC lifted its position in IDEX by 18.6% in the 3rd quarter. Parallel Advisors LLC now owns 664 shares of the industrial products company’s stock valued at $108,000 after acquiring an additional 104 shares in the last quarter. Institutional investors and hedge funds own 97.96% of the company’s stock.

Key Stories Impacting IDEX

Here are the key news stories impacting IDEX this week:

  • Positive Sentiment: IDEX beat both top‑line and bottom‑line estimates for Q4 — $2.10 EPS vs. consensus ~ $2.04 and revenue of $899.1M (up ~4.2% YoY) with healthy margins and ROE — signaling continued operational strength. Article Title
  • Positive Sentiment: Management released a slide deck and press release alongside results, providing detail on drivers behind the beat (useful for investors assessing sustainability of growth). Press Release / Slides
  • Neutral Sentiment: Analysts and outlets are processing the quarter and guidance; some coverage highlights the company’s strong business fundamentals but flags valuation as a consideration. Article Title
  • Negative Sentiment: IDEX set Q1 FY26 EPS guidance at $1.73–1.78 (consensus ~ $1.84) and FY26 EPS at $8.15–8.35 (consensus ~ $8.31) — ranges that are modestly below analysts’ expectations and could cap near‑term upside. Article Title

Analysts Set New Price Targets

IEX has been the topic of a number of recent analyst reports. Oppenheimer set a $210.00 target price on shares of IDEX in a research note on Tuesday, October 7th. TD Cowen reissued a “buy” rating on shares of IDEX in a report on Wednesday, December 3rd. Royal Bank Of Canada reiterated an “outperform” rating and set a $211.00 price objective on shares of IDEX in a research note on Thursday, January 15th. Stifel Nicolaus upped their price objective on IDEX from $200.00 to $220.00 and gave the company a “buy” rating in a report on Friday, January 23rd. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of IDEX in a research report on Wednesday, October 8th. Five research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $203.29.

Check Out Our Latest Analysis on IDEX

IDEX Company Profile

(Get Free Report)

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.

Recommended Stories